rxstatShortages › Belimumab

Belimumab shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Belimumab has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 2
Reports on file
3

Reports by product

Resolved
BENLYSTA
400MG · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02370069 · ended Mar 30, 2026 · Demand increase for the drug.
Resolved
BENLYSTA
120MG · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02370050 · ended Feb 6, 2024 · Disruption of the manufacture of the drug.
Resolved
BENLYSTA
400MG · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02370069 · ended Oct 18, 2018 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Belimumab. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Recent changes

Common questions

When will Belimumab be back in stock in Canada?

Belimumab has no active shortage; supply is normal per Health Canada reports.

Why is Belimumab in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.